Sharda Cropchem Ltd

Sharda Cropchem Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sharda Cropchem Ltd

₹ 884 -7.36%
30 Oct - close price
shardacropchem.com BSE: 538666 NSE: SHARDACROP
About

Sharda Cropchem is principally engaged in export of agrochemicals (technical grade and formulations) and non-agro products such as conveyor belts, rubber belts/sheets, dyes and dye intermediates to various countries across the world.

Key Points

Business Segments

Website BSE NSE
  • Market Cap ₹ 7,974 Cr.
  • Current Price ₹ 884
  • High / Low ₹ 1,181 / 440
  • Stock P/E 17.6
  • Book Value ₹ 297
  • Dividend Yield 1.02 %
  • ROCE 16.5 %
  • ROE 12.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 42.5%

Cons

  • Stock is trading at 2.98 times its book value
  • Company has a low return on equity of 9.89% over last 3 years.
  • Company has high debtors of 165 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals

Part of BSE SmallCap BSE Allcap BSE Commodities Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
722 1,017 1,482 638 581 632 1,312 785 777 929 1,829 985 929
656 810 1,164 697 560 563 1,057 708 687 815 1,525 770 796
Operating Profit 65 207 318 -59 21 69 255 77 90 115 303 215 133
OPM % 9% 20% 21% -9% 4% 11% 19% 10% 12% 12% 17% 22% 14%
10 3 7 26 24 12 -2 19 25 1 25 32 29
Interest 0 1 2 1 5 1 0 1 0 0 0 1 0
Depreciation 60 65 68 70 74 69 54 65 69 69 72 78 76
Profit before tax 15 143 255 -105 -34 12 198 31 46 46 256 169 86
Tax % 17% 24% 22% -15% -18% 62% 28% 11% 7% 32% 20% 16% 13%
12 108 199 -89 -28 5 143 27 42 31 204 143 74
EPS in Rs 1.34 12.01 22.04 -9.82 -3.06 0.51 15.90 3.02 4.70 3.45 22.56 15.83 8.24
Raw PDF
Upcoming result date: today

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
790 1,061 1,222 1,399 1,707 1,998 2,003 2,396 3,580 4,045 3,163 4,320 4,672
630 878 941 1,075 1,343 1,621 1,653 1,945 2,884 3,386 2,860 3,705 3,906
Operating Profit 160 183 281 324 364 376 350 450 696 659 303 615 766
OPM % 20% 17% 23% 23% 21% 19% 17% 19% 19% 16% 10% 14% 16%
32 25 23 14 9 -22 -12 46 29 40 60 60 88
Interest 8 9 8 9 15 20 16 16 15 20 24 21 2
Depreciation 29 23 35 56 70 99 137 170 245 248 267 275 295
Profit before tax 155 175 261 272 287 235 185 309 464 431 72 378 557
Tax % 29% 30% 33% 30% 34% 25% 11% 26% 25% 21% 56% 20%
111 123 175 190 191 176 165 229 349 342 32 304 452
EPS in Rs 12.31 13.63 19.41 21.11 21.14 19.55 18.25 25.40 38.71 37.90 3.53 33.74 50.08
Dividend Payout % 16% 18% 21% 19% 19% 20% 22% 20% 16% 16% 85% 27%
Compounded Sales Growth
10 Years: 15%
5 Years: 17%
3 Years: 6%
TTM: 33%
Compounded Profit Growth
10 Years: 10%
5 Years: 8%
3 Years: -5%
TTM: 107%
Stock Price CAGR
10 Years: 13%
5 Years: 26%
3 Years: 33%
1 Year: 23%
Return on Equity
10 Years: 15%
5 Years: 12%
3 Years: 10%
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 90 90 90 90 90 90 90 90 90 90 90 90 90
Reserves 466 564 715 870 1,045 1,194 1,313 1,524 1,822 2,142 2,147 2,410 2,585
40 38 2 0 170 0 0 81 47 3 18 8 4
319 354 522 686 914 914 940 1,163 1,779 2,108 1,773 2,205 2,224
Total Liabilities 914 1,047 1,329 1,646 2,219 2,198 2,343 2,858 3,738 4,343 4,028 4,713 4,903
64 88 130 210 226 372 416 544 592 668 708 750 1,109
CWIP 133 149 210 232 360 220 161 131 212 204 283 291 0
Investments 174 95 90 61 22 212 116 83 134 32 159 294 555
542 715 899 1,143 1,611 1,394 1,650 2,099 2,800 3,439 2,878 3,377 3,240
Total Assets 914 1,047 1,329 1,646 2,219 2,198 2,343 2,858 3,738 4,343 4,028 4,713 4,903

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
156 46 197 181 17 556 146 246 267 328 341 604
-145 -19 -113 -104 -160 -351 -59 -282 -205 -112 -393 -496
-22 -24 -89 -38 132 -215 -60 43 -91 -97 -37 -68
Net Cash Flow -11 3 -6 40 -11 -11 27 8 -29 120 -89 40

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 185 156 185 175 191 148 180 177 157 165 173 165
Inventory Days 57 72 74 117 169 96 100 117 130 145 155 117
Days Payable 146 117 179 186 202 167 180 180 172 176 144 158
Cash Conversion Cycle 97 111 81 106 158 77 100 114 115 134 184 124
Working Capital Days 67 82 95 99 94 71 101 94 88 97 128 92
ROCE % 28% 27% 36% 32% 27% 23% 18% 21% 26% 21% 4% 16%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
74.82% 74.82% 74.82% 74.82% 74.82% 74.82% 74.82% 74.82% 74.82% 74.82% 74.82% 74.82%
2.41% 2.14% 2.00% 2.01% 2.06% 2.14% 2.02% 2.52% 3.77% 4.69% 5.48% 5.26%
12.61% 12.93% 12.75% 12.29% 12.42% 12.41% 12.87% 12.77% 10.07% 10.28% 9.38% 9.26%
10.15% 10.09% 10.44% 10.87% 10.70% 10.63% 10.29% 9.91% 11.33% 10.21% 10.33% 10.65%
No. of Shareholders 61,10654,22252,12656,48356,85861,07554,43648,35358,71751,18762,03067,290

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls